Ruben Niesvizky

Director of the Multiple Myeloma Center · Weill Cornell Medical College

Credentials: · · ·

History

Exploiting Novel Therapeutic Targets in Multiple Myeloma (k23m)
National Cancer Institute · K23
Contact PI · $680.4K · Weill Medical Coll of Cornell Univ
2004–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $86.6K · Weill Medical Coll of Cornell Univ
2004–2007

Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma
Principal investigator · Terminated · Phase 1, Phase 2
Weill Medical College of Cornell University
2013–2016
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University
2012–2026
Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma
Principal investigator · Completed · Phase 3
Weill Medical College of Cornell University
2011–2019
Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
Principal investigator · Completed · Phase 2
Weill Medical College of Cornell University
2010–2015